4-HydroxythiobenzamideCAS# 25984-63-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 25984-63-8 | SDF | Download SDF |
PubChem ID | 5706487 | Appearance | Powder |
Formula | C7H7NOS | M.Wt | 153 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 4-[amino(sulfanyl)methylidene]cyclohexa-2,5-dien-1-one | ||
SMILES | C1=CC(=O)C=CC1=C(N)S | ||
Standard InChIKey | DOCQBKMMNPJLOR-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C7H7NOS/c8-7(10)5-1-3-6(9)4-2-5/h1-4,10H,8H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
4-Hydroxythiobenzamide Dilution Calculator
4-Hydroxythiobenzamide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.5359 mL | 32.6797 mL | 65.3595 mL | 130.719 mL | 163.3987 mL |
5 mM | 1.3072 mL | 6.5359 mL | 13.0719 mL | 26.1438 mL | 32.6797 mL |
10 mM | 0.6536 mL | 3.268 mL | 6.5359 mL | 13.0719 mL | 16.3399 mL |
50 mM | 0.1307 mL | 0.6536 mL | 1.3072 mL | 2.6144 mL | 3.268 mL |
100 mM | 0.0654 mL | 0.3268 mL | 0.6536 mL | 1.3072 mL | 1.634 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Hyponine D
Catalog No.:BCC8998
CAS No.:259823-31-9
- T 705
Catalog No.:BCC4130
CAS No.:259793-96-9
- 2-Deacetyltaxuspine X
Catalog No.:BCN7375
CAS No.:259678-73-4
- 5-Hydroxy-7-methoxy-3-(4-hydroxybenzylidene)chroman-4-one
Catalog No.:BCN1472
CAS No.:259653-54-8
- 5-Acetyl-3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine
Catalog No.:BCC8726
CAS No.:25961-11-9
- Allura Red AC
Catalog No.:BCN2220
CAS No.:25956-17-6
- EDC.HCl
Catalog No.:BCC2812
CAS No.:25952-53-8
- HOBt (anhydrous)
Catalog No.:BCC2816
CAS No.:2592-95-2
- Boc-Lys(Boc)-ONp
Catalog No.:BCC3414
CAS No.:2592-19-0
- Boc-Thr-OH
Catalog No.:BCC3449
CAS No.:2592-18-9
- 3'-Hydroxydehydroaglaiastatin
Catalog No.:BCN7725
CAS No.:259143-58-3
- D-Luciferin
Catalog No.:BCC6535
CAS No.:2591-17-5
- Nimbolide
Catalog No.:BCN8053
CAS No.:25990-37-8
- Xylose
Catalog No.:BCC4880
CAS No.:25990-60-7
- GI 254023X
Catalog No.:BCC2374
CAS No.:260264-93-5
- Zamanic acid
Catalog No.:BCN5131
CAS No.:260393-05-3
- Dihydroisotanshinone II
Catalog No.:BCN5132
CAS No.:260397-58-8
- Ligustroflavone
Catalog No.:BCN2370
CAS No.:260413-62-5
- PD173955
Catalog No.:BCC3999
CAS No.:260415-63-2
- Beauvericin
Catalog No.:BCC6546
CAS No.:26048-05-5
- Boc-Asp(OBzl)-ONp
Catalog No.:BCC3364
CAS No.:26048-69-1
- 1-Isomangostin hydrate
Catalog No.:BCN5133
CAS No.:26063-95-6
- 3-Isomangostin hydrate
Catalog No.:BCN5134
CAS No.:26063-96-7
- Sotetsuflavone
Catalog No.:BCN3846
CAS No.:2608-21-1
Long-term release of a thiobenzamide from a backbone functionalized poly(lactic acid).[Pubmed:26870159]
Polym Chem. 2015 Oct;6(40):7188-7195.
Hydrogen sulfide is emerging as a critically important molecule in medicine, yet there are few methods for the long-term delivery of molecules that degrade to release H2S. In this paper the first long-term release of a thiobenzamide that degrades to release H2S is described. A series of polymers were synthesized by the copolymerization of L-lactide and a lactide functionalized with 4-Hydroxythiobenzamide. A new method to attach functional groups to a derivative of L-lactide is described based on the addition of a thiol to an alpha,beta-unsaturated lactide using catalytic I2. This reaction proceeded under mild conditions and did not ring-open the lactone. The copolymers had molecular weights from 8 to 88 kg mol(-1) with PDIs below 1.50. Two sets of microparticles were fabricated from a copolymer; the average diameters of the microparticles were 0.53 and 12 mum. The degradation of the smaller microparticles was investigated in buffered water to demonstrate the slow release of thiobenzamide over 4 weeks. Based on the ability to synthesize polymers with different loadings of thiobenzamide and that thiobenzamide is a known precursor to H2S, these particles provide a polymer-based method to deliver H2S over days to weeks.
Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents.[Pubmed:26809888]
J Med Chem. 2016 Mar 10;59(5):1776-90.
This work deals with the design, synthesis, and evaluation of the cardioprotective properties of a number of novel hybrid compounds combining the adenine nucleus with a suitable H2S slow-releasing moiety, coupled via a stable ether bond. The H2S release rate of the hybrids and their ability to increase cGMP were estimated in vitro. The most promising derivatives 4 and 11, both containing 4-Hydroxythiobenzamide moiety as H2S donor, were selected for further in vivo evaluation. Their ability to release H2S in vivo was recorded using a new fully validated UPLC-DAD method. Both compounds reduced significantly the infarct size when administered at the end of sustained ischemia. Mechanistic studies showed that they conferred enhanced cardioprotection compared to adenine or 4-Hydroxythiobenzamide. They activate the PKG/PLN pathway in the ischemic myocardium, suggesting that the combination of both pharmacophores results in synergistic cardioprotective activity through the combination of both molecular pathways that trigger cardioprotection.
Vibrational spectra, NBO, HOMO-LUMO and conformational stability studies of 4-hydroxythiobenzamide.[Pubmed:25827766]
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Aug 5;147:51-66.
In this work, the experimental and theoretical study on molecular structure, vibrational spectral analysis of 4-Hydroxythiobenzamide (HTB) have been reported. The solid phase FTIR (4000-400 cm(-1)) and FT-Raman spectra (3500-50 cm(-1)) were recorded. The molecular geometry, harmonic vibrational frequencies and bonding features of HTB in the ground-state have been calculated by the density functional method (B3LYP) with 6-311+G(d,p) and 6-311++G(d,p) as basis sets. Utilizing the observed FTIR and FT-Raman data, a complete vibrational assignment and analysis of the fundamental modes of the compound were carried out. Stability of the molecule arising from hyperconjugative interactions, charge delocalization has been analyzed using natural bond orbital (NBO) analysis. The results show that the value of electron density (ED) in the sigma( *) antibonding orbitals and E((2)) energies confirms the occurrence of ICT (intra-molecular charge transfer) within the molecule. The UV spectrum was measured in ethanol solution. The energy and oscillator strength calculated by time-dependent density functional theory (TD-DFT) correlates with the experimental findings. The calculated molecular electrostatic potential (MESP), HOMO and LUMO energies show that charge transfer occurs within the molecule. Besides, the simulated infrared and Raman spectra of the title compound which show good agreement with observed spectra.